Kirkland Advises Germfree on Acquisition of Arcoplast

Kirkland & Ellis advised Germfree Laboratories on the acquisition of Arcoplast, the maker of the leading seamless primary barrier cleanroom wall and ceiling system for Life Science applications and more. The acquisition will allow Germfree to offer comprehensive facility solutions from the ground up and follows 17 years of collaboration between the companies, during which Arcoplast has supplied architectural systems for Germfree installations at over 200 facilities globally. Germfree is backed by the healthcare growth equity investor, EW Healthcare Partners.

Read the transaction press release

The Kirkland team included corporate lawyers Marshall Shaffer, Daniel Yip and Amir Farahani; and tax lawyers Mike Beinus and Vivek Ratnam.